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Obesity is a multifactorial, highly complex medical 
condition involving abnormal or excessive body fat accu-
mulation that can cause health impairment. Epidemiological 
studies suggest that the prevalence and severity of obesity 
have increased to epidemic proportions worldwide, making it 
a global public health problem. It has been estimated that 937 
million people are overweight and 328 million obese glob-
ally [1,2]. Obesity can lead to islet β-cell failure, increased 
insulin resistance, and subsequently type 2 diabetes mellitus 
[3]. Moreover, obesity is a potential risk factor for a wide 
variety of pathologies [4-6]. The cluster of interconnected 
factors that increase the risk of obesity-induced diabetes 
mellitus, cardiovascular/atherosclerotic lesions, chronic 
kidney diseases, hypertension, stroke, and some types of 
cancer are collectively referred to as metabolic syndrome 
(MetS) [7,8]. Ophthalmic complications reported to be 
associated with MetS include retinopathy, high intraocular 
pressure, cataract, macular degeneration, and exophthalmitis 
[9,10]. The alarming increase in the prevalence of obesity or 
MetS is likely to further exacerbate the risk for ophthalmic 
abnormalities associated with obesity. Retinal diseases, 
including age-related macular degeneration (AMD), retinitis 
pigmentosa (RP), and diabetic retinopathy (DR), represent 
the leading cause of irreversible blindness in developed and 
developing countries [11,12]. AMD and RP are the most 
common degenerative diseases of the retina. While AMD 
is characterized by a loss of central vision, RP is typically 
characterized as a rod–cone dystrophy leading to the loss of 
rod and cone photoreceptors, and predominantly the degen-
eration of rod photoreceptors [13-15]. Establishing model 
systems will enable us to understand the molecular pathology 
of these diseases.
In several populations, obesity is one of the basic 
components of MetS, which is implicated in microvascular 
changes in the retina [16]. Further, retinal degeneration 
has been reported as a component of obesity-associated 
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Purpose: Metabolic syndrome (MetS) is associated with several degenerative diseases, including retinal degeneration. 
Previously, we reported on progressive retinal degeneration in a spontaneous obese rat (WNIN/Ob) model. In this study, 
we investigated the additional effect of impaired glucose tolerance (IGT), an essential component of MetS, on retinal 
degeneration using the WNIN/GR-Ob rat model.
Methods: The retinal morphology and ultrastructure of WNIN/GR-Ob and age-matched littermate lean rats were studied 
by microscopy and immunohistochemistry. The retinal transcriptome of WNIN/GR-Ob was compared with the respec-
tive lean controls and with the WNIN/Ob model using microarray analysis. Expression of selected retinal marker genes 
was studied via real-time PCR.
Results: Progressive loss of photoreceptor cells was observed in WNIN/GR-Ob rats with an onset as early as 3 months. 
Similarly, thinning of the inner nuclear layer was observed from 6 months in these rats. Immunohistochemical analysis 
showed decreased levels of rhodopsin and postsynaptic density protein-95 (PSD-95) proteins and increased levels of 
glial fibrillary acidic protein (GFAP), vascular endothelial growth factor (VEGF), and calretinin in WNIN/GR-Ob rats 
compared with the age-matched lean controls, further supporting cellular stress/damage and retinal degeneration. The 
retinal transcriptome analysis indicated altered expression profiles in both the WNIN/GR-Ob and WNIN/Ob rat models 
compared to their respective lean controls; these pathways are associated with activation of pathways like cellular 
oxidative stress response, inflammation, apoptosis, and phototransduction, although the changes were more prominent 
in WNIN/GR-Ob than in WNIN/Ob animals.
Conclusions: WNIN/GR-Ob rats with added glucose intolerance developed retinal degeneration similar to the parent line 
WNIN/Ob. The severity of retinal degeneration was greater in WNIN/GR-Ob rats compared to WNIN/Ob, suggesting a 
possible role for IGT in this model. Hence, the WNIN/GR-Ob model could be a valuable tool for investigating the impact 
of MetS on retinal degeneration pathology.
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syndrome in both patients and mouse models with mutations 
in Tub and Bardet–Biedl syndrome (BBS) genes [17-19]. 
However, obesity develops along with or much later than 
retinal changes in tubby mice and mouse models of BBS. 
Earlier, we reported progressive retinal degeneration as a 
consequence of obesity in a spontaneously generated obese 
rat (WNIN/Ob) [19]. This model was isolated and developed 
from the existing Wistar stock of rats at the National Institute 
of Nutrition (WNIN) [20,21]. Subsequently, another strain 
with impaired glucose tolerance (IGT), WNIN/GR-Ob, was 
developed by mating the WNIN/Ob strain with an insulin-
resistance strain [22]. In essence, WNIN/GR-Ob has the IGT 
trait, while WNIN/Ob does not. Hence, the WNIN/Ob and 
WNIN/GR-Ob phenotypes are distinct from their respective 
lean littermates in terms of various biochemical, histological, 
and pathophysiological features [22-24]. Genetic analysis of 
this model localized the disease gene to the region upstream 
to the leptin receptor [25]. By taking advantage of the WNIN/
GR-Ob rat model, in this study, we investigated the effect 
of MetS, glucose intolerance (IGT), and obesity on retinal 
degeneration.
METHODS
Materials: An RNA purification kit was obtained from 
Qiagen (Hilden, Germany). The High-Capacity cDNA 
Reverse Transcription Kit and Power SYBR Green Master 
Mix were obtained from Applied Biosystems (Warrington, 
UK). All primers were procured from Integrated DNA Tech-
nologies (Coralville, IA). Mouse monoclonal anti-rhodopsin 
(1:1000 dilution; Thermo Scientific), mouse anti-postsynaptic 
density protein-95 (PSD-95; 1:200 dilution; Sigma-Aldrich, 
St. Louis, MO), recombinant anti-calretinin (1:1000 dilu-
tion; Chemi-Con, Millipore, Billerica), anti–glial fibrillary 
acidic protein (GFAP; 1:500 dilution; Sigma-Aldrich), and 
anti–vascular endothelial growth factor (VEGF; 1:50 dilu-
tion; Thermo Scientific) were used. Vectashield mounting 
medium containing 4,6-diamidino-2-phenylindole (DAPI) 
was obtained from Vector Laboratories (Burlingame, CA). 
Alexa Fluor 488–conjugated anti-rabbit and Alexa Fluor 
555–conjugated anti-mouse antibodies were obtained from 
Molecular Probes (Eugene, OR). An in situ cell death detec-
tion kit was obtained from Roche Diagnostics (GmBH, 
Mannheim, Germany).
Animals and tissue collection: WNIN/GR-Ob and WNIN/Ob 
rats were obtained from the National Center for Laboratory 
Figure 1. Histology of the retina in various age groups. A: Representative hematoxylin and eosin (H&E) images of the WNIN/GR-Ob rat 
retina at 3, 6, 12, and 15 months of age in comparison with age-matched lean rats. B: Representative ultrastructural (electron microscope) 
images. Histograms summarizing the number of cells in the ONL (C) and INL (D) of the central retina of WNIN/GR-Ob rats compared to 
respective age-matched lean rats based on H&E analyses. Values represent mean ± standard deviation (SD; n = 3; “*” significantly different 
from their respective lean rats at p≤0.05). ROS, retinal outer segment; RIS, retinal inner segment; ONL, outer nuclear layer; OPL, outer 
plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GC, ganglion cell layer.
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Animal Sciences (NCLAS), National Institute of Nutrition, 
Hyderabad (India). Animals were kept on a 12 h:12 h light-
dark cycle with ambient light and temperature at the NCLAS. 
WNIN/GR-Ob rats that were 3, 6, 12, and 15 months old, 
along with their respective lean littermates, were fasted over-
night and sacrificed by CO2 asphyxiation at the end of the 
dark cycle. All procedures involving rats were performed in 
accordance with the Association for Research in Vision and 
Ophthalmology (ARVO) statement for the use of Animals 
in Ophthalmic and Vision Research and were approved by 
the Institutional Animal Ethics Committee at the National 
Institute of Nutrition. All studies described were performed 
by evaluating at least three animals.
Figure 2. Immunohistochemical evaluation of expression of retinal markers in 12-month-old WNIN/GR-Ob rats. The expression value of 
each bar was compared to its respective age-matched lean rat which is taken as 1 (or 100%) for calculating the fold change. A-F: rhodopsin, 
G-L: glial fibrillary acidic protein (GFAP), and M-R: vascular endothelial growth factor (VEGF). Nuclei are labeled with 4,6-diamidino-
2-phenylindole (DAPI). Scale bar, 50 µm.
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Histology and immunohistochemistry: Eyes extracted from 
three rats in each age group were processed for embedding 
and sectioning using standard protocols, as described previ-
ously [19,26]. One eye of each rat was used for morphological 
evaluation, while the fellow eye was used for immunohis-
tochemistry. Eyeballs were fixed in 4% paraformaldehyde 
in phosphate-buffer (pH 7.2), followed by embedding and 
sectioning for paraffin or cryosections. While the sections 
stained with hematoxylin and eosin were analyzed by light 
microscopy for retinal morphology, the ultrastructure was 
analyzed by electron microscopy. Immunohistochemistry 
on retinas of 12-month-old rats was performed on paraffin 
sections. The transverse sections (4 μm) were mounted in 
silane coated slides. Deparaffinized sections were processed 
in 10 mM sodium citrate buffer (pH 6.0) and heated for 
antigen retrieval. After blocking, the respective primary 
antibodies were added to the sections in a volume of 100 μl 
and allowed to incubate overnight at 4 °C. After incubation, 
the sections were washed three times for 5 min in PBS, and 
100 μl of respective Alexa Fluor-555 and Alexa Fluor-488 
secondary antibodies solution was added. After washing, the 
slides were mounted in anti-fade reagent containing DAPI 
and observed under a Leica LMD 6000 microscope (Wetzlar, 
Germany). Images were captured using appropriate filters.
Figure 3. Immunohistochemical evaluation of expression of postsynaptic density protein 95 (PSD-95) and calretinin in 12-month-old WNIN/
GR-Ob rat. A-F: PSD-95 and G-L: calretinin. Nuclei are labeled with 4,6-diamidino-2-phenylindole (DAPI). Scale bar, 50 µm.
Molecular Vision 2017; 23:263-274 <http://www.molvis.org/molvis/v23/263> © 2017 Molecular Vision 
267
Global gene expression by transcriptome analysis: Five 
micrograms of total retinal RNA from 3- and 12-month-old 
WNIN/GR-Ob and WNIN/Ob rats, along with the respective 
age-matched lean rats (isolated from two pooled retinas from 
each age group), were used to synthesize double-stranded 
cDNA (ds-cDNA) using a first and second strand cDNA 
synthesis kit (Affymetrix, Santa Clara, CA) according to the 
manufacturer’s guidelines. Basically, total RNA was reverse 
transcribed to cDNA which is converted to ds-cDNA. Puri-
fication of ds-cDNA, labeling, hybridization, washing, and 
staining steps were performed according to the Affymetrix 
protocol. These procedures or protocols are available at 
the Affymetrix website.The rat Gene 1.0 ST Array Chip 
(Affymetrix) was used for hybridization. Gene chips were 
scanned (Microarray Suite 5.0 [Affymetrix] by GCOS 
software version 2.0), and expression data were normalized 
using robust multiarray averaging [27]. Data were based on 
three gene chips per age group (WNIN/GR-Ob and WNIN/
Ob and the respective lean rats). Data quality control (QC) 
was performed on arrays as recommended by Affymetrix, 
and Robust Multi-array Average (RMA) summarized data 
were subsequently analyzed for differential expression. The 
QC analysis was performed using the Affymetrix Expres-
sion Console (EC), and the statistical analysis was performed 
using R programming language. Ratios of average signal 
intensity (Log2-transformed data) were calculated for the 
Figure 4. Expression of rod-specific genes by quantitative real-time PCR (qRT-PCR). A: Rho, B: Sag, C: Gnat1 and D: Pde-6b in 3-, 6-, 12-, 
and 15-month-old WNIN/GR-Ob rats. The expression value of each bar was compared to its respective age-matched lean rat which is taken 
as 1 (or 100%) for calculating the fold change. Data represent fold change (mean ± standard deviation [SD]) over respective age-matched 
lean rats (n = 3; “*” p<0.05). “*” significantly different from the respective age-matched lean rats at p≤0.05.
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probe sets and converted to fold change relative to the respec-
tive lean rats [19,27]. A term was significant if p≤0.05; then it 
was considered to be enriched with genes. Accordingly, the 
further biological relevance of the term and the associated 
genes was explored. Previously, we used the rat gene expres-
sion chip (230.20; Affymetrix) for the studies on WNIN/
Ob rat model ([19]. Therefore, we also analyzed the retinal 
transcriptome of WNIN/Ob model for comparison purpose 
using the rat Gene 1.0 ST Array Chip.
Quantitative real-time PCR: Total RNA was extracted from 
retina using Tri-reagent. Isolated RNA was further purified 
by RNeasy Mini Kit and quantified by measuring the absor-
bance at 260 and 280 nm on a spectrophotometer (NanoDrop 
Technologies, Delaware). Two micrograms of total RNA 
were reverse transcribed using a High Capacity cDNA 
Reverse Transcription Kit. The reverse transcription reaction 
was performed using a thermocycler (ABI 9700, Applied 
Biosystems, Foster City, CA), and reaction conditions were 
as follows: initial reverse transcription for 10 min at 25 °C, 
followed by 37 °C for 120 min and 84 °C for 5 min. Real-time 
PCR (RT-PCR; Applied Biosystems) was performed in tripli-
cate with 25 ng of cDNA template using SYBR Green Master 
Mix with gene-specific primers (Appendix 1). The reaction 
conditions were as follows: 40 cycles of initial denaturation 
temperature at 95 °C for 30 s, followed by annealing at 52 °C 
for 40 s, and extension at 72 °C for 1 min. The product speci-
ficity was analyzed using melt curve analysis. Normalization 
and validation of data were performed using β-actin as an 
internal control, and data were compared between WNIN/
GR-Ob and the age-matched lean samples according to the 
comparative threshold cycle (2-ΔΔct) method. Student t tests 
were used to compare the mean values among different 
Figure 5. Expression of cone markers and Crx by quantitative real-time PCR (qRT-PCR) and immunohistochemistry. The expression value 
of each bar was compared to its respective age-matched lean rat which is taken as 1 (or 100%) for calculating the fold change. A: Expression 
of cone-specific genes (Opnl MW and Gnat2) and rod–cone transcriptional marker Crx in 3-,6-, 12- and 15-month-old WNIN/GR-Ob rats. 
Data represent fold change (mean ± standard deviation [SD]) over respective age-matched lean rats (n = 3; “*” p<0.05). “*” significantly 
different from the respective age-matched lean rats at p≤0.05. B: Immunohistochemical evaluation of expression of cone marker M-opsin 
in 12-month-old WNIN/GR-Ob and respective lean rats. Nuclei are labeled with 4,6-diamidino-2-phenylindole (DAPI). Arrows indicate 
staining of M-opsin. Scale bar, 50 µm.
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groups for a given age. Values of p<0.05 were considered 
significant.
RESULTS
Morphological changes: Progressive alterations in 
morphology were observed in the retinas of WNIN/GR-Ob 
rats from 3 months of age onwards (Figure 1). At 6 months, 
the thickness of the photoreceptor and outer plexiform layer 
(OPL) in the central retina of WNIN/GR-Ob rats was reduced 
when compared to lean rats and further reduced by 12 months 
(approximately 50–60% of that of lean rats; Figure 1A-B). 
Further damage of photoreceptors and the OPL was observed 
in the central regions of 15-month-old WNIN/GR-Ob rats 
compared to lean animals (Figure 1A-B). A concomitant 
decrease occurred in outer nuclear layer (ONL) and inner 
nuclear layer (INL) thickness of the retina at 6, 12, and 15 
months, demonstrating abnormalities in the retinal layers as 
observed by hematoxylin and eosin (H&E) staining (Figure 
1C-D). These results indicate progressive degeneration of 
retinal cells of WNIN/GR-Ob rats.
Immunohistochemistry: Immunohistochemical analyses were 
performed using retinas from 12-month-old WNIN/GR-Ob 
rats and various retinal cell-specific markers. Immunos-
taining using the rhodopsin antibody showed a substantially 
reduced signal in the WNIN/GR-Ob rat retina compared with 
that of lean control rats (Figure 2A-F). GFAP staining on the 
Figure 6. Expression of stress-related genes by quantitative real-time PCR (qRT-PCR). There are three corrections. A: Vegf, B: αA-crystallin, 
C: αB-crystallin, and D: Gfap in 3-, 6-, 12-, and 15-month-old WNIN/GROb. Data represent fold change (mean ± SD) over respective age-
matched lean rats (n = 3; “*” p<0.05). The expression value of each bar was compared to its respective age-matched lean rat which is taken 
as 1 (or 100%) for calculating the fold change. “*” significantly different from the respective age-matched lean rats at p≤0.05.
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WNIN/GR-Ob rat retina showed a strong signal not only in 
the ganglion cell layer (GCL) but also in the other layers of 
the retina compared to lean rats (Figure 2G-L). Similarly, 
immunostaining of VEGF in 12-month-old WNIN/GR-Ob 
rats showed an increased signal compared to lean rats (Figure 
2M-R). PSD-95 staining of retinal sections from WNIN/
GR-Ob rats showed a substantial reduction compared to age-
matched lean rats (Figure 3A-F). Labeling of horizontal and 
aII amacrine cells with calretinin showed increased immu-
nostaining in retinas from WNIN/GR-Ob rats compared to 
the respective lean rats (Figures 3G-L). Fundoscopy also 
confirmed the retinal damage. Moreover, neovascularization 
was apparent in the WNIN/GR-Ob rats (data not shown).
qRT-PCR analysis: We analyzed the expression of selected 
retinal genes in retinas from WNIN/GR-Ob rats by quantita-
tive RT-PCR (qRT-PCR) at 3, 6, 12, and 15 months of age. 
Compared to the respective lean controls, the expressions of 
the rod-specific genes Rho, rod arrestin (Sag), rod transducin 
(Gnat1) and cGMP-dependent phosphodiesterase 6B (Pde6B) 
were reduced in the WNIN/GR-Ob rat retina from 6 months 
onward, but they were significantly lower at 12 and 15 months 
of age (Figure 4A-D). In contrast, the expressions of cone 
markers, Opnl-MW and Gnat2, were higher in retinas from 
the WNIN/GR-Ob rats, particularly at 12 and 15 months of 
age (Figure 5A). Immunohistochemical staining of a cone 
marker, M-opsin, consolidated the observations of cone 
marker expression at the transcript level (Figure 5B). The 
expression level of a retinal transcription factor, cone–rod 
homeobox gene (Crx), was decreased significantly in all age 
groups in WNIN/GR-Ob when compared to the lean controls 
(Figure 5A). The transcript levels of stress-related genes of the 
retina, such as vegf, gfap, αA-crystallin, and αB-crystallin, 
were upregulated from 3 months onward in WNIN/GR-Ob 
rats, with some comparisons reaching statistical significance 
(Figure 6A-D).
Microarray analysis and validation: Selecting those genes 
with an adjusted p-value of 0.05 and a threefold difference, 
we found 191 genes differentially expressed in the WNIN/
GR-Ob retina at 3 months of age; of these, 167 showed lower 
levels of expression, while 24 genes’ expressions were found 
to be significantly higher than in lean controls (Appendix 2). 
In the case of WNIN/Ob rats, extremely few differentially 
Figure 7. Top four altered cellular functions/diseases associated with obesity and metabolic syndrome (MetS). Cellular functions and diseases 
associated with the differentially expressed genes in WNIN/Ob and WNIN/GR-Ob (with respect to their corresponding lean controls) were 
identified using a cellular functional analysis tool available in Ingenuity Pathway Analysis (IPA; Ingenuity Systems, Redwood City, CA). 
Dark blue bars represent WNIN/Ob and light-blue bars represent WNIN/GR-Ob rats.
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expressed genes (39 downregulated and 9 upregulated) were 
observed in the retina at 3 months compared to age-matched 
lean control rats. However, at 12 months of age, transcriptome 
analysis resulted in 561 genes, of which 454 were downregu-
lated and 107 genes were upregulated in the WNIN/GR-Ob 
rat retina when compared to the lean controls. In the case 
of WNIN-Ob rats, we measured 334 differentially expressed 
genes (303 downregulated and 31 upregulated) compared to 
the lean controls. Genes involved in various functional path-
ways or diseases were identified using a cellular functional 
analysis tool available in Ingenuity Pathway Analysis (IPA; 
Ingenuity Systems, Redwood City, CA) [28]. As reported 
earlier with WNIN/Ob, while most downregulated genes in 
this study were related to the visual cycle, phototransduc-
tion pathway, or retinal structural proteins or transcription 
factors, upregulated genes were related to the stress response 
and inflammation-related genes. Based on IPA, the top five 
predicted diseases are connected to nervous system devel-
opment and function, cell-to-cell signaling and interaction, 
ophthalmic diseases, tissue morphology, and visual system 
development and function (Figure 7). Furthermore, the 
extent of alterations in these cellular functions was greater 
in the WNIN/GR-Ob rat retina compared to the WNIN/Ob 
rat retina (Figure 7). To validate the observations by micro-
array analysis, qRT-PCR analysis of selected retinal genes, 
namely CryβA2, Rpe65, Slc24a5, Cp, and Tyr, was performed 
in retinas from 12-month-old lean and WNIN/GR-Ob rats 
(Figure 8). The results were consistent with those of the 
microarray data.
DISCUSSION
Epidemiological studies have revealed a relationship between 
obesity and retinal abnormalities [24,29-32]. Studies on 
animal models corroborate the association between obesity 
and retinal degeneration. In the case of tubby mice, neuro-
sensory abnormalities develop much earlier than the onset of 
obesity. Further, the obesity in tubby mice is relatively mild, 
exhibits a late onset, and progresses slowly [17,18]. Among 
other rodent models of obesity, ocular complications—
pronounced retinal alterations in particular—were found in 
diabetic ( fa/fa) obese rats when they were sucrose diet fed 
for 68 weeks [30]. A suitable rodent model of obesity along 
with glucose intolerance and retinal degeneration is needed to 
investigate the effect of MetS on retinal degeneration. MetS 
is a cluster of interrelated metabolic derangements, including 
Figure 8. Expression of CrybA2, 
Rpe65, Slc24a5, Cp, and Tyr by 
quantitative real-time PCR (qRT-
PCR) of the retina in 12 months old 
WNIN/GR-Ob rat. Data represent 
fold change (mean ± standard 
deviation [SD]) over respective 
age-matched lean rats (n = 3; “*” 
p<0.05).
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disturbances in glucose and insulin metabolism, abdominal 
obesity, an abnormal lipid profile and high blood pressure, all 
of which were observed in WNIN/GR-Ob rats, making this a 
suitable model of MetS [24,31].
We previously reported retinal degeneration in a spon-
taneous obese rat (WNIN/Ob) model [19]. However, WNIN/
Ob did not display IGT; hence, it is not a typical model of 
MetS. In contrast, the WNIN/GR-Ob rat is unique because 
of traits of IGT and obesity that are similar to those of MetS. 
Hence, in this study, we investigated retinal abnormalities 
in the WNIN/GR-Ob rat model. In the case of the WNIN/
Ob model, no significant changes were observed in retinal 
morphology at 2–3 months of age, and the onset of retinal 
abnormalities was observed between 4 and 6 months of age 
[19]. In contrast changes were evident as early as 3 months of 
age in WNIN/GR-Ob rats, and these progressed further with 
age. These observations suggest an additional effect of IGT 
along with obesity on the retinal phenotype.
In the case of WNIN/Ob rats, there was a nearly 50% 
reduction in rhodopsin staining at 12 months [19]. A substan-
tial reduction (roughly 90%) in rhodopsin was observed in 
WNIN/GR-Ob compared to respective lean rats. In addition, 
staining of another retinal marker, PSD-95 also decreased 
by almost 90% in WNIN/GR-Ob rats compared to respec-
tive lean rats. In concurrence with the loss of photoreceptor 
cells, there was an increase in the gliosis marker, GFAP, in 
WNIN/GR-Ob rats, which gives further evidence of atrophy 
in the retina. There was an increase in the angiogenic protein 
VEGF and calcium binding protein calretinin (inner retinal 
marker) in WNIN/GR-Ob rats. The expression pattern of 
these genes at transcript levels in the WNIN/GR-Ob rat retina 
also supports photoreceptor degeneration. The downregulated 
genes appear to be involved predominantly in transcriptional 
regulation (Crx) and visual transduction (Gnat, Pde6B, Sag, 
and Rho). The downregulation of rod cell specific genes 
may reflect the loss of photoreceptors rather than decreased 
expression of these genes. In several types of retinal degener-
ation, in patients and animal models, rod cell death precedes 
cone loss [33,34]. We observed preservation of cones in the 
WNIN/Ob model at 12 months of age, when rod degenera-
tion was significant, although we did not analyze these rats 
beyond 12 months of age [19]. Interestingly, in WNIN/GR-Ob 
rats, cones did not seem to be affected even at 15 months of 
age. These findings support our earlier speculation that the 
molecular defect underlying retinal degeneration in these rats 
is associated with a biological pathway that is critical for rod 
cell survival [19]. Further, both these rat models of obesity 
and MetS (WNIN/Ob and WNIN/GR-Ob) with spared cone 
cells despite significant rod cell loss may aid in understanding 
possible means to preserve cones in the absence of rods.
Earlier, we analyzed global gene expression in the retina 
of WNIN/Ob model at only 12 months of age, and signifi-
cant changes in the retina were noted. Since we found that 
retinal alterations were earlier and more severe in WNIN/
GR-Ob than in the WNIN/Ob model, we analyzed the global 
gene expression at 3 and 12 months in the WNIN/GR-Ob 
and WNIN/Ob models using the respective age-matched lean 
rats as controls. We found a higher number of differentially 
expressed (DE) genes in the WNIN/GR-Ob retina compared 
to the WNIN/Ob retina at 3 months. This further supports 
the earlier onset of a retinal phenotype in WNIN/GR-Ob 
rats compared to WNIN/Ob rats. Similarly, transcriptome 
analysis at 12 months of age resulted in 561 DE genes (454 
downregulated and 107 upregulated) in WNIN/GR-Ob rat 
retinas. Using the rat gene expression 230.20 chip, we previ-
ously measured 423 DE genes (369 downregulated and 54 
upregulated) in the WNIN/Ob rat [19], but in the present 
study with the rat gene 1.0 ST Array, we measured 334 DE 
genes (303 downregulated and 31 upregulated) in WNIN/Ob 
rats. Although the cellular functional analysis and associated 
diseases of the transcriptome data showed a similar pattern in 
both the models, the extent of fold changes in gene expression 
was greater in the WNIN/GR-Ob model compared to WNIN/
Ob rats (Figure 7), indicating an added influence of IGT 
along with obesity on retinal dystrophies. Upregulation of 
stress-related genes, Cp, Tyr, αA, and αB, was observed in the 
WNIN/GR-Ob rat retina by microarray and qRT-PCR (Figure 
6); such upregulation has also been reported for some other 
retinal disorders [35,36]. It should be noted that crystallin 
betaA2 (Cryba2), which has been shown to be associated 
with cataract [37], was upregulated in the WNIN/GR-Ob 
rats. In contrast, Rpe65 (retinoid isomerohydrolase), which 
has been reported to be involved in visual pigment regenera-
tion [38], was downregulated in WNIN/GR-Ob rats. Solute 
carrier family 24 member 5 (Slc24a5), upregulated in WNIN/
GR-Ob, has been shown to be associated with oculocutaneous 
albinism [39].
In summary, WNIN/GR-Ob rats showed earlier onset and 
severe retinal degeneration when compared with the WNIN/
Ob rats. The reason for this could be the added IGT along 
with obesity in WNIN/GR-Ob rats. Hence, this rat model 
of MetS may be useful for investigating MetS-associated 
retinal degeneration, as well as for developing intervention 
strategies.
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APPENDIX 1. PRIMER SEQUENCES OF GENES 
USED FOR REAL-TIME PCR.
To access the data, click or select the words “Appendix 1.”
APPENDIX 2. NUMBER OF DIFFERENTIALLY 
EXPRESSED GENES IN RETINA BASED ON 
MICROARRAY ANALYSIS OF WNIN/GR-OB AND 
WNIN/OB RAT (COMPARED TO RESPECTIVE 
LEAN CONTROLS).
To access the data, click or select the words “Appendix 2.”
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